COMMENTARY: Generic medications pose more questions than answers

In recent years, in most countries almost all medical specialties have been faced by the emergence of new players: generic medications. They have entered the field of interest and the lives of many individuals, caregivers, payers and eventually the patients themselves, who are the final "targets" of drugs; generics have slowly become a societal matter of concern, Alain Bron, MD, said in the latest issue of Ocular Surgery News: Europe Edition.

Even though ophthalmology is a small slice of the big pharmaceutical expenses pie (no more than 1.5% on average, depending on the country), we are faced now with the fact that something new is not always something better.

In recent years, in most countries almost all medical specialties have been faced by the emergence of new players: generic medications. They have entered the field of interest and the lives of many individuals, caregivers, payers and eventually the patients themselves, who are the final "targets" of drugs; generics have slowly become a societal matter of concern, Alain Bron, MD, said in the latest issue of Ocular Surgery News: Europe Edition.

Even though ophthalmology is a small slice of the big pharmaceutical expenses pie (no more than 1.5% on average, depending on the country), we are faced now with the fact that something new is not always something better.